Frank Gerberick Receives Award for Advancing Alternatives
November 24, 2014
Alternatives Research & Development Foundation
Frank Gerberick, a scientist at the Procter & Gamble Company, based in Cincinnati, Ohio, received the William and Eleanor Cave Award last week at a private reception in Bethesda, Maryland.
The Award was presented by the Alternatives Research & Development Foundation (ARDF) of Jenkintown, Pennsylvania, before a gathering of dozens of colleagues at the third Annual Meeting of the American Society for Cellular and Computational Toxicology (ASCCT).
ARDF President Sue Leary explained, “This recognition is for Frank Gerberick’s impressive career achievements in developing alternative test methods. He has been a real leader in the field.” Dr. Gerberick began his alternatives research in late 1980s, and in January 2014, European authorities accepted the Direct Peptide Reactivity Assay (DPRA), an alternative test method his team developed for skin sensitization. Over the years, he has been an author on over 160 scientific articles, and received numerous awards and honors for his work, including the Society of Toxicology’s Animal Welfare Award.
See full details here.